Europe Faces Climate Onslaught, FDA Boosts Infant Formula Safety, ELREXFIO Shows Promise in Myeloma, AI Tool Redefines Obesity Risk, and more...

(0:10): Europe's 2025 Climate Extremes Demand Urgent Action: Heatwaves, Water Crisis, and Energy Challenges(2:15): FDA Enhances Infant Formula Safety with New Testing and Transparency Measures(4:24): Pfizer's ELREXFIO Shows Promising Results in Phase 3 Trial for Relapsed Multiple Myeloma(7:07): New AI Tool Obscore Revolutionizes Obesity Risk Detection, Prioritizes Early Intervention Over BMI Reliance(9:14): Ariane 6 Set to Launch 32 Amazon Leo Satellites on Ambitious VA268 MissionTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: logo